Genomic and Proteomic Determinants of Outcome in Patients Undergoing Thoracoabdominal Aortic Aneurysm Repair1

[1]  Steven C. Lawlor,et al.  MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data , 2003, Genome Biology.

[2]  T. Huber,et al.  Functional outcome after thoracoabdominal aortic aneurysm repair. , 2002, Journal of vascular surgery.

[3]  T. Poggio,et al.  Prediction of central nervous system embryonal tumour outcome based on gene expression , 2002, Nature.

[4]  M. Adams,et al.  Implications of the human genome for understanding human biology and medicine. , 2001, JAMA.

[5]  D. Botstein,et al.  Diversity of gene expression in adenocarcinoma of the lung , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Mesirov,et al.  Chemosensitivity prediction by transcriptional profiling , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[7]  L. Moldawer,et al.  SEPSIS SYNDROMES: UNDERSTANDING THE ROLE OF INNATE AND ACQUIRED IMMUNITY , 2001, Shock.

[8]  T. Huber,et al.  The outcome in the United States after thoracoabdominal aortic aneurysm repair, renal artery bypass, and mesenteric revascularization. , 2001, Journal of vascular surgery.

[9]  Christine Brun,et al.  In silico prediction of protein-protein interactions in human macrophages , 2001, BMC Research Notes.

[10]  A. Mansfield,et al.  Transcription Factor NF&kgr;B Expression and Postsurgical Organ Dysfunction , 2001, Annals of surgery.

[11]  L. Moldawer,et al.  The relationship between visceral ischemia, proinflammatory cytokines, and organ injury in patients undergoing thoracoabdominal aortic aneurysm repair , 2000, Critical care medicine.

[12]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[13]  F. Moore.  The role of the gastrointestinal tract in postinjury multiple organ failure. , 1999, American journal of surgery.

[14]  L. Moldawer,et al.  Discordant tumor necrosis factor-alpha superfamily gene expression in bacterial peritonitis and endotoxemic shock. , 1999, Surgery.

[15]  E. Abraham,et al.  Why immunomodulatory therapies have not worked in sepsis , 1999, Intensive Care Medicine.

[16]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[17]  Kinalska,et al.  CD23 Antigen Expression on B Lymphocytes and Soluble CD23 Levels in Peripheral Blood of High‐Risk Type 1 Diabetes Subjects , 1999, Scandinavian journal of immunology.

[18]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Vincent.  Search for effective immunomodulating strategies against sepsis , 1998, The Lancet.

[20]  M. Mireskandari,et al.  Visceral ischemia and neutrophil activation in sepsis and organ dysfunction. , 1998, The Journal of surgical research.

[21]  J. Bland,et al.  Plasma proinflammatory cytokine concentrations, Acute Physiology and Chronic Health Evaluation (APACHE) III scores and survival in patients in an intensive care unit. , 1996, Critical care medicine.

[22]  L. Moldawer,et al.  Visceral ischemia and organ dysfunction after thoracoabdominal aortic aneurysm repair. A clinical and cost analysis. , 1996, Annals of surgery.

[23]  M. Cuesta,et al.  Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome. , 1996, Blood.

[24]  C. Hack,et al.  Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis. , 1995, Blood.

[25]  P. Barie,et al.  Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients. , 1994, Journal of the American College of Surgeons.

[26]  J. Coselli,et al.  Variables predictive of outcome in 832 patients undergoing repairs of the descending thoracic aorta. , 1993, Chest.

[27]  A C Allison,et al.  The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. , 1990, The Journal of clinical investigation.

[28]  E. Lander,et al.  A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.